4SC Investor Relations Material
Latest events
Q2 2024
4SC
Q1 2025
17 Apr, 2025
Q4 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 4SC AG
Access all reports
4SC AG is a Germany-based biotechnology company focused on the development of small-molecule drugs for the treatment of cancer. The company’s research centers on epigenetic cancer therapies, particularly those aimed at modulating the immune system and tumor microenvironment. Its operations encompass drug discovery, clinical development, and regulatory activities. 4SC AG is headquartered in Planegg-Martinsried, Germany, and its shares are listed on the XETRA.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
VSC
Country
🇩🇪 Germany